Last 12 months
Inside the activity.
1 purchase rows · 87 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 20 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 1 | 4 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2025 Filed Feb 19, 2025 22:49 UTC |
Rowland Stephen EricPresident
|
ConversionSeries B Common Stock · Derivative | 28,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000020 · wk-form4_1740005345.xml · derivative · entry 5 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 513,120 Underlying: Series A Common Stock · 28,264 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · balance_after: Consists of 513,120 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:49 UTC |
Rowland Stephen EricPresident
|
ConversionSeries B Common Stock · Derivative | 23,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000020 · wk-form4_1740005345.xml · derivative · entry 4 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,384 Underlying: Series A Common Stock · 23,048 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 23,048 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:49 UTC |
Rowland Stephen EricPresident
|
ConversionSeries A Common Stock | 28,264 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000020 · wk-form4_1740005345.xml · nonDerivative · entry 3 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · balance_after: Consists of (i) 130,025 shares of Series A Common Stock and (ii) 152,939 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:49 UTC |
Rowland Stephen EricPresident
|
Tax withholdingSeries A Common Stock | 28,751 | $47.00 | $1,351,297.00 |
DisclosureSEC source: 0001835830-25-000020 · wk-form4_1740005345.xml · nonDerivative · entry 2 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,700 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:49 UTC |
Rowland Stephen EricPresident
|
ConversionSeries A Common Stock | 23,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000020 · wk-form4_1740005345.xml · nonDerivative · entry 1 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 23,048 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:51 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 18,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000021 · wk-form4_1740005478.xml · derivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,114 Underlying: Series A Common Stock · 18,944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 18,944 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · balance_after: Consists of (i) 181,739 shares of Series B Common Stock and (ii) 334,375 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:51 UTC |
Whalen AmandaChief Financial Officer
|
Tax withholdingSeries A Common Stock | 31,141 | $47.00 | $1,463,627.00 |
DisclosureSEC source: 0001835830-25-000021 · wk-form4_1740005478.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,623 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. F4 · balance_after: Consists of (i) 45,707 shares of Series A Common Stock and (ii) 318,916 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 22:51 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 18,944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000021 · wk-form4_1740005478.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 18,944 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:26 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 1,700 | $44.54 | $75,718.00 |
DisclosureSEC source: 0001835830-25-000007 · wk-form4_1738704413.xml · nonDerivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,820 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.19 to $44.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Consists of (i) 26,911 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 349,909 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:26 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 3,516 | $45.00 | $158,220.00 |
DisclosureSEC source: 0001835830-25-000007 · wk-form4_1738704413.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 378,520 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.74 to $45.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:26 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 9,784 | $46.39 | $453,879.76 |
DisclosureSEC source: 0001835830-25-000007 · wk-form4_1738704413.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 382,036 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.77 to $46.76 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:09 UTC |
Rowland Stephen EricPresident
|
ConversionSeries B Common Stock · Derivative | 78,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000005 · wk-form4_1737148168.xml · derivative · entry 3 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 564,432 Underlying: Series A Common Stock · 78,154 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · balance_after: Consists of 564,432 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:09 UTC |
Rowland Stephen EricPresident
|
SaleSeries A Common Stock | 4,536 | $40.04 | $181,621.44 |
DisclosureSEC source: 0001835830-25-000005 · wk-form4_1737148168.xml · nonDerivative · entry 2 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,403 F2 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.53 to $40.48 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 94,719 shares of Series A Common Stock and (ii) 165,684 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:09 UTC |
Rowland Stephen EricPresident
|
ConversionSeries A Common Stock | 78,154 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000005 · wk-form4_1737148168.xml · nonDerivative · entry 1 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:58 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-25-000001 · wk-form4_1736553508.xml · derivative · entry 4 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 535,058 Underlying: Series A Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F6 · balance_after: Consists of (i) 152,766 shares of Series B Common Stock and (ii) 382,292 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:58 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 3,541 | $38.68 | $136,965.88 |
DisclosureSEC source: 0001835830-25-000001 · wk-form4_1736553508.xml · nonDerivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 391,820 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.34 to $38.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Consists of (i) 41,911 shares of Series A Common Stock and (ii) 349,909 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:58 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 11,459 | $39.34 | $450,797.06 |
DisclosureSEC source: 0001835830-25-000001 · wk-form4_1736553508.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,361 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.90 to $39.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:58 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-25-000001 · wk-form4_1736553508.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 406,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 00:02 UTC |
Edmond LandonChief Legal Officer
|
SaleSeries A Common Stock | 25,207 | $41.62 | $1,049,115.34 |
DisclosureSEC source: 0001835830-25-000003 · wk-form4_1736553714.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298,607 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.22 to $41.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 79,642 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 218,965 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 07, 2025 Filed Jan 11, 2025 00:02 UTC |
Edmond LandonChief Legal Officer
|
SaleSeries A Common Stock | 14,793 | $42.10 | $622,785.30 |
DisclosureSEC source: 0001835830-25-000003 · wk-form4_1736553714.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 323,814 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $42.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:36 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries B Common Stock · Derivative | 101,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000121 · wk-form4_1734557773.xml · derivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,500 Underlying: Series A Common Stock · 101,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F3 · balance_after: Consists of 97,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of the Issuer's Series B Common Stock upon vesting and settlement. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:36 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries A Common Stock | 101,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000121 · wk-form4_1734557773.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · balance_after: Consists of (i) 119,642 shares of Series A Common Stock and (ii) 218,965 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:38 UTC |
Rowland Stephen EricPresident
|
ConversionSeries B Common Stock · Derivative | 4,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000122 · wk-form4_1734557915.xml · derivative · entry 5 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 642,586 Underlying: Series A Common Stock · 4,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F7 · balance_after: Consists of (i) 78,154 shares of Series B Common Stock and (ii) 564,432 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:38 UTC |
Rowland Stephen EricPresident
|
SaleSeries A Common Stock | 300 | $39.49 | $11,847.00 |
DisclosureSEC source: 0001835830-24-000122 · wk-form4_1734557915.xml · nonDerivative · entry 4 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,785 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.42 to $39.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Consists of (i) 21,101 shares of Series A Common Stock and (ii) 165,684 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:38 UTC |
Rowland Stephen EricPresident
|
SaleSeries A Common Stock | 2,800 | $40.13 | $112,364.00 |
DisclosureSEC source: 0001835830-24-000122 · wk-form4_1734557915.xml · nonDerivative · entry 3 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,085 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.59 to $40.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:38 UTC |
Rowland Stephen EricPresident
|
SaleSeries A Common Stock | 1,436 | $41.42 | $59,479.12 |
DisclosureSEC source: 0001835830-24-000122 · wk-form4_1734557915.xml · nonDerivative · entry 2 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,885 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.16 to $41.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:38 UTC |
Rowland Stephen EricPresident
|
ConversionSeries A Common Stock | 4,536 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000122 · wk-form4_1734557915.xml · nonDerivative · entry 1 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 13, 2024 Filed Dec 14, 2024 01:49 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 11,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000120 · wk-form4_1734140939.xml · derivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 550,058 Underlying: Series A Common Stock · 11,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · balance_after: Consists of (i) 167,766 shares of Series B Common Stock and (ii) 382,292 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| December 13, 2024 Filed Dec 14, 2024 01:49 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 15,000 | $39.39 | $590,850.00 |
DisclosureSEC source: 0001835830-24-000120 · wk-form4_1734140939.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 391,820 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.02 to $39.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 41,911 shares of Series A Common Stock and (ii) 349,909 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| December 13, 2024 Filed Dec 14, 2024 01:49 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 11,204 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000120 · wk-form4_1734140939.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 406,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 12, 2024 Filed Dec 14, 2024 01:47 UTC |
Weisman TonyDirector
|
ConversionSeries B Common Stock · Derivative | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000119 · wk-form4_1734140862.xml · derivative · entry 4 Weisman Tony · CIK 0001716921 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 0 Underlying: Series A Common Stock · 20,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F3 · ownership.nature: Shares held by Tony G. Weisman TTEE Tony G. Weisman Declaration of Trust Dated 06-27-2000, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. Read SEC document |
| December 12, 2024 Filed Dec 14, 2024 01:47 UTC |
Weisman TonyDirector
|
ConversionSeries B Common Stock · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000119 · wk-form4_1734140862.xml · derivative · entry 3 Weisman Tony · CIK 0001716921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 12, 2024 Filed Dec 14, 2024 01:47 UTC |
Weisman TonyDirector
|
ConversionSeries A Common Stock | 20,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000119 · wk-form4_1734140862.xml · nonDerivative · entry 2 Weisman Tony · CIK 0001716921 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 20,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F3 · ownership.nature: Shares held by Tony G. Weisman TTEE Tony G. Weisman Declaration of Trust Dated 06-27-2000, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. Read SEC document |
| December 12, 2024 Filed Dec 14, 2024 01:47 UTC |
Weisman TonyDirector
|
ConversionSeries A Common Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000119 · wk-form4_1734140862.xml · nonDerivative · entry 1 Weisman Tony · CIK 0001716921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · balance_after: Consists of (i) 75,000 shares of Series A Common Stock and (ii) 8,532 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| December 09, 2024 Filed Dec 9, 2024 22:27 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000118 · wk-form4_1733783231.xml · derivative · entry 6 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 561,262 Underlying: Series A Common Stock · 1,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F6 · balance_after: Consists of (i) 178,970 shares of Series B Common Stock and (ii) 382,292 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| December 09, 2024 Filed Dec 9, 2024 22:27 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 1,050 | $40.07 | $42,073.50 |
DisclosureSEC source: 0001835830-24-000118 · wk-form4_1733783231.xml · nonDerivative · entry 4 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,616 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Consists of (i) 45,707 shares of Series A Common Stock and (ii) 349,909 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| December 09, 2024 Filed Dec 9, 2024 22:27 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 1,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000118 · wk-form4_1733783231.xml · nonDerivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 396,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:57 UTC |
SUMMIT PARTNERS L P10% owner
Summit Partners Co-Invest (Kiwi), LP10% owner
SUMMIT INVESTORS GE IX/VC IV, LLC10% owner
|
ConversionSeries B Common Stock, par value $0.001 per share · Derivative | 2,100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135422 · ownership.xml · derivative · entry 3 SUMMIT PARTNERS L P · CIK 0000830588 · 10% owner Summit Partners Growth Equity Fund IX-A, L.P. · CIK 0001634415 · 10% owner Summit Partners Growth Equity Fund IX-B, L.P. · CIK 0001634426 · 10% owner Summit Partners Co-Invest (Kiwi), LP · CIK 0001830877 · 10% owner SUMMIT INVESTORS GE IX/VC IV, LLC · CIK 0001654074 · 10% owner SUMMIT INVESTORS GE IX/VC IV (UK), L.P. · CIK 0001846709 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 40,827,778 Underlying: Series A Common Stock, par value $0.001 per share · 2,100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series B common stock, par value $0.001 per share ("Series B Common Stock"), is convertible into an equal number of shares of Series A common stock, par value $0.001 per share ("Series A Common Stock"), at any time, at the holder's election, and has no expiration date. Each share of Series B Common Stock will automatically convert into Series A Common Stock upon the earlier of (i) the date specified by 66-2/3% of the outstanding shares of Series B Common Stock, voting as a single series; (ii) following the seventh anniversary of the closing of Klaviyo, Inc.'s (the "Company") initial public offering; or (iii) any transfer, whether or not for value, except for certain permitted transfers described in the Company's certificate of incorporation. On December 9, 2024, the reporting persons directed the sale of an aggregate of 2,100,000 shares of their Series B Common Stock, resulting in the automatic conversion of the shares into Series A Common Stock upon execution of the sale. F1 · derivative.exercise_date: The Series B common stock, par value $0.001 per share ("Series B Common Stock"), is convertible into an equal number of shares of Series A common stock, par value $0.001 per share ("Series A Common Stock"), at any time, at the holder's election, and has no expiration date. Each share of Series B Common Stock will automatically convert into Series A Common Stock upon the earlier of (i) the date specified by 66-2/3% of the outstanding shares of Series B Common Stock, voting as a single series; (ii) following the seventh anniversary of the closing of Klaviyo, Inc.'s (the "Company") initial public offering; or (iii) any transfer, whether or not for value, except for certain permitted transfers described in the Company's certificate of incorporation. On December 9, 2024, the reporting persons directed the sale of an aggregate of 2,100,000 shares of their Series B Common Stock, resulting in the automatic conversion of the shares into Series A Common Stock upon execution of the sale. F1 · derivative.expiration_date: The Series B common stock, par value $0.001 per share ("Series B Common Stock"), is convertible into an equal number of shares of Series A common stock, par value $0.001 per share ("Series A Common Stock"), at any time, at the holder's election, and has no expiration date. Each share of Series B Common Stock will automatically convert into Series A Common Stock upon the earlier of (i) the date specified by 66-2/3% of the outstanding shares of Series B Common Stock, voting as a single series; (ii) following the seventh anniversary of the closing of Klaviyo, Inc.'s (the "Company") initial public offering; or (iii) any transfer, whether or not for value, except for certain permitted transfers described in the Company's certificate of incorporation. On December 9, 2024, the reporting persons directed the sale of an aggregate of 2,100,000 shares of their Series B Common Stock, resulting in the automatic conversion of the shares into Series A Common Stock upon execution of the sale. F5 · balance_after: Consists of (i) 24,130,130 shares of Series B Common Stock held by Fund IX-A, (ii) 15,066,515 shares of Series B Common Stock held by Fund IX-B, (iii) 1,487,851 shares of Series B Common Stock held by Kiwi Co-Invest Fund, (iv) 126,822 shares of Series B Common Stock held by Fund IX/VC IV, and (v) 16,460 shares of Series B Common Stock held by Fund IX/VC IV (UK). F2 · ownership.nature: Summit Partners, L.P. is the manager of Summit Partners GE IX, LLC, which is the general partner of Summit Partners GE IX, LP, which is the general partner of Summit Partners Growth Equity Fund IX-A, L.P. ("Fund IX-A") and Summit Partners Growth Equity Fund IX-B, L.P. ("Fund IX-B"). Summit Partners, L.P. is the managing member of Summit Partners Co-Invest Kiwi GP, LLC, which is the general partner of Summit Partners Co-Invest (Kiwi), L.P. ("Kiwi Co-Invest Fund"). Summit Master Company, LLC is the general partner of Summit Partners, L.P., which is the manager of Summit Investors Management, LLC, which is the manager of Summit Investors GE IX/VC IV, LLC ("Fund IX/VC IV") and the general partner of Summit Investors GE IX/VC IV (UK), L.P. ("Fund IX/VC IV (UK)"). F3 · ownership.nature: (continued from footnote 2) Summit Master Company, LLC, as the managing member of Summit Investors Management, LLC, has delegated voting and investment decisions with respect to the Series B Common Stock held by Fund IX/VC IV and Fund IX/VC IV (UK) to Summit Partners, L.P. F4 · ownership.nature: The investment committee of Summit Partners, L.P., is currently composed of Peter Y. Chung, Scott C. Collins, and Peter L. Rottier, who may be deemed to have voting and dispositive authority over, and therefore beneficial ownership of, the reported securities. Each of the foregoing entities, Mr. Chung, Mr. Collins, and Mr. Rottier disclaims beneficial ownership of the shares, except to the extent of such person's or entity's pecuniary interest therein and the filing of this statement shall not be deemed an admission that any of the foregoing entities or persons are, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any equity securities covered by this statement. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:57 UTC |
SUMMIT PARTNERS L P10% owner
Summit Partners Co-Invest (Kiwi), LP10% owner
SUMMIT INVESTORS GE IX/VC IV, LLC10% owner
|
SaleSeries A Common Stock, par value $0.001 per share | 2,100,000 | $39.15 | $82,215,000.00 |
DisclosureSEC source: 0000950170-24-135422 · ownership.xml · nonDerivative · entry 2 SUMMIT PARTNERS L P · CIK 0000830588 · 10% owner Summit Partners Growth Equity Fund IX-A, L.P. · CIK 0001634415 · 10% owner Summit Partners Growth Equity Fund IX-B, L.P. · CIK 0001634426 · 10% owner Summit Partners Co-Invest (Kiwi), LP · CIK 0001830877 · 10% owner SUMMIT INVESTORS GE IX/VC IV, LLC · CIK 0001654074 · 10% owner SUMMIT INVESTORS GE IX/VC IV (UK), L.P. · CIK 0001846709 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F2 · ownership.nature: Summit Partners, L.P. is the manager of Summit Partners GE IX, LLC, which is the general partner of Summit Partners GE IX, LP, which is the general partner of Summit Partners Growth Equity Fund IX-A, L.P. ("Fund IX-A") and Summit Partners Growth Equity Fund IX-B, L.P. ("Fund IX-B"). Summit Partners, L.P. is the managing member of Summit Partners Co-Invest Kiwi GP, LLC, which is the general partner of Summit Partners Co-Invest (Kiwi), L.P. ("Kiwi Co-Invest Fund"). Summit Master Company, LLC is the general partner of Summit Partners, L.P., which is the manager of Summit Investors Management, LLC, which is the manager of Summit Investors GE IX/VC IV, LLC ("Fund IX/VC IV") and the general partner of Summit Investors GE IX/VC IV (UK), L.P. ("Fund IX/VC IV (UK)"). F3 · ownership.nature: (continued from footnote 2) Summit Master Company, LLC, as the managing member of Summit Investors Management, LLC, has delegated voting and investment decisions with respect to the Series B Common Stock held by Fund IX/VC IV and Fund IX/VC IV (UK) to Summit Partners, L.P. F4 · ownership.nature: The investment committee of Summit Partners, L.P., is currently composed of Peter Y. Chung, Scott C. Collins, and Peter L. Rottier, who may be deemed to have voting and dispositive authority over, and therefore beneficial ownership of, the reported securities. Each of the foregoing entities, Mr. Chung, Mr. Collins, and Mr. Rottier disclaims beneficial ownership of the shares, except to the extent of such person's or entity's pecuniary interest therein and the filing of this statement shall not be deemed an admission that any of the foregoing entities or persons are, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any equity securities covered by this statement. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:57 UTC |
SUMMIT PARTNERS L P10% owner
Summit Partners Co-Invest (Kiwi), LP10% owner
SUMMIT INVESTORS GE IX/VC IV, LLC10% owner
|
ConversionSeries A Common Stock, par value $0.001 per share | 2,100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-135422 · ownership.xml · nonDerivative · entry 1 SUMMIT PARTNERS L P · CIK 0000830588 · 10% owner Summit Partners Growth Equity Fund IX-A, L.P. · CIK 0001634415 · 10% owner Summit Partners Growth Equity Fund IX-B, L.P. · CIK 0001634426 · 10% owner Summit Partners Co-Invest (Kiwi), LP · CIK 0001830877 · 10% owner SUMMIT INVESTORS GE IX/VC IV, LLC · CIK 0001654074 · 10% owner SUMMIT INVESTORS GE IX/VC IV (UK), L.P. · CIK 0001846709 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series B common stock, par value $0.001 per share ("Series B Common Stock"), is convertible into an equal number of shares of Series A common stock, par value $0.001 per share ("Series A Common Stock"), at any time, at the holder's election, and has no expiration date. Each share of Series B Common Stock will automatically convert into Series A Common Stock upon the earlier of (i) the date specified by 66-2/3% of the outstanding shares of Series B Common Stock, voting as a single series; (ii) following the seventh anniversary of the closing of Klaviyo, Inc.'s (the "Company") initial public offering; or (iii) any transfer, whether or not for value, except for certain permitted transfers described in the Company's certificate of incorporation. On December 9, 2024, the reporting persons directed the sale of an aggregate of 2,100,000 shares of their Series B Common Stock, resulting in the automatic conversion of the shares into Series A Common Stock upon execution of the sale. F2 · ownership.nature: Summit Partners, L.P. is the manager of Summit Partners GE IX, LLC, which is the general partner of Summit Partners GE IX, LP, which is the general partner of Summit Partners Growth Equity Fund IX-A, L.P. ("Fund IX-A") and Summit Partners Growth Equity Fund IX-B, L.P. ("Fund IX-B"). Summit Partners, L.P. is the managing member of Summit Partners Co-Invest Kiwi GP, LLC, which is the general partner of Summit Partners Co-Invest (Kiwi), L.P. ("Kiwi Co-Invest Fund"). Summit Master Company, LLC is the general partner of Summit Partners, L.P., which is the manager of Summit Investors Management, LLC, which is the manager of Summit Investors GE IX/VC IV, LLC ("Fund IX/VC IV") and the general partner of Summit Investors GE IX/VC IV (UK), L.P. ("Fund IX/VC IV (UK)"). F3 · ownership.nature: (continued from footnote 2) Summit Master Company, LLC, as the managing member of Summit Investors Management, LLC, has delegated voting and investment decisions with respect to the Series B Common Stock held by Fund IX/VC IV and Fund IX/VC IV (UK) to Summit Partners, L.P. F4 · ownership.nature: The investment committee of Summit Partners, L.P., is currently composed of Peter Y. Chung, Scott C. Collins, and Peter L. Rottier, who may be deemed to have voting and dispositive authority over, and therefore beneficial ownership of, the reported securities. Each of the foregoing entities, Mr. Chung, Mr. Collins, and Mr. Rottier disclaims beneficial ownership of the shares, except to the extent of such person's or entity's pecuniary interest therein and the filing of this statement shall not be deemed an admission that any of the foregoing entities or persons are, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any equity securities covered by this statement. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 22:27 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 23,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000118 · wk-form4_1733783231.xml · derivative · entry 5 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 562,312 Underlying: Series A Common Stock · 23,950 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 22:27 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 23,950 | $40.04 | $958,958.00 |
DisclosureSEC source: 0001835830-24-000118 · wk-form4_1733783231.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 395,616 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.11 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 22:27 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 23,950 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000118 · wk-form4_1733783231.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 419,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 21:05 UTC |
SUMMIT PARTNERS L P10% owner
|
OtherSeries A Common Stock, par value $0.001 per share | 346,707 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-130550 · ownership.xml · nonDerivative · entry 1 SUMMIT PARTNERS L P · CIK 0000830588 · 10% owner Summit Partners Growth Equity Fund IX-A, L.P. · CIK 0001634415 · 10% owner Summit Partners Growth Equity Fund IX-B, L.P. · CIK 0001634426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · kind: Represents a distribution of 213,439 shares of Series A common stock, par value $0.001 per share ("Series A Common Stock") held by Summit Partners Growth Equity Fund IX-A, L.P. ("Fund IX-A") and 133,268 shares of Series A Common Stock held by Summit Partners Growth Equity Fund IX-B, L.P. ("Fund IX-B"), in each case to facilitate bona fide charitable gifts. F2 · ownership.nature: Summit Partners, L.P. is the manager of Summit Partners GE IX, LLC, which is the general partner of Summit Partners GE IX, LP, which is the general partner of Fund IX-A and Fund IX-B. The investment committee of Summit Partners, L.P., is currently composed of Peter Y. Chung, Scott C. Collins, and Peter L. Rottier, who may be deemed to have voting and dispositive authority over, and therefore beneficial ownership of, the reported securities. Each of the foregoing entities, Mr. Chung, Mr. Collins, and Mr. Rottier disclaims beneficial ownership of the shares, except to the extent of such person's or entity's pecuniary interest therein and the filing of this statement shall not be deemed an admission that any of the foregoing entities or persons are, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any equity securities covered by this statement. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 23:11 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries B Common Stock · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000113 · wk-form4_1732057869.xml · derivative · entry 6 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 199,486 Underlying: Series A Common Stock · 40,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F7 · balance_after: Consists of (i) 101,986 shares of Series B Common Stock and (ii) 97,500 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 23:11 UTC |
Edmond LandonChief Legal Officer
|
SaleSeries A Common Stock | 40,000 | $34.56 | $1,382,400.00 |
DisclosureSEC source: 0001835830-24-000113 · wk-form4_1732057869.xml · nonDerivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 236,621 F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.13 to $34.99 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Consists of (i) 17,656 shares of Series A Common Stock and (ii) 218,965 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 23:11 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries A Common Stock | 40,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000113 · wk-form4_1732057869.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 23:12 UTC |
Rowland Stephen EricPresident
|
ConversionSeries B Common Stock · Derivative | 4,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001835830-24-000114 · wk-form4_1732057965.xml · derivative · entry 6 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 647,122 Underlying: Series A Common Stock · 4,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F7 · balance_after: Consists of (i) 82,690 shares of Series B Common Stock and (ii) 564,432 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 23:12 UTC |
Rowland Stephen EricPresident
|
SaleSeries A Common Stock | 4,536 | $34.56 | $156,764.16 |
DisclosureSEC source: 0001835830-24-000114 · wk-form4_1732057965.xml · nonDerivative · entry 4 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,785 F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.21 to $34.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · balance_after: Consists of (i) 21,101 shares of Series A Common Stock and (ii) 165,684 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 23:12 UTC |
Rowland Stephen EricPresident
|
ConversionSeries A Common Stock | 4,536 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001835830-24-000114 · wk-form4_1732057965.xml · nonDerivative · entry 3 Rowland Stephen Eric · CIK 0001639368 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 191,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2024. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.